Portfolio
LSP HEF 2
Investments range between EUR 10 million and EUR 30 million
LSP HEF 2 (Health Economic Fund) seeks to invest in health care technology companies in late-stage development or early-stage commercialization. Products or technologies need to have the potential to improve the quality of healthcare and lower the cost of care at the same time. LSP HEF 2’s geographical focus is primarily Europe and the US.
LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands
Company Registration Number: 34296447
LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.
Fast facts
- StatusActive
- Launch2018
- SizeEUR 280 m
- SFDR classificationArt. 8
Investment advisory committee
- ChairpersonAndre Olijslager
- CompanySectorCountryEntryExit
- Simplify MedicalHealthcareUnited States20172021
- One ProjectsHealthcareIreland/Germany2020
- Luma VisionHealthcareIreland/Germany2020
- NobiHealthcareBelgium2022
- Fundamental VRHealthcareUnited Kingdom2022
- VicentraHealthcareNetherlands2016
- Neurent MedicalHealthcareIreland2020
- PerfuzeHealthcareIreland2022
- XeltisHealthcareNetherlands2014
- DOTS TechnologyHealthcareUnited States2021
- Atlantic TherapeuticsHealthcareIreland2018
- iStar MedicalHealthcareBelgium2019
- LumeonHealthcareUnited Kingdom20182024
- EndotronixHealthcareUnited States20182024